Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


The evolution of the myelin sheath throughout childhood has been visualised for a first time, and the findings reported in the study Mapping An Index Of The Myelin G-ratio In Infants Using...

What if doctors could change your diet and reduce the chances of developing multiple sclerosis? That’s what Brigham and Women’s researchers are suggesting, after discovering the bacteria living in...

‘Rebound syndrome’ following cessation of Gilenya for multiple sclerosis occurs at a clinically relevant rate, shows research, prompting the need for further study on how best to sequence and...

A once-monthly injection for multiple sclerosis from Biogen and AbbVie has been recommended for approval by European regulators, paving the way for its launch in the coming months.

The...

Researchers at the Center of Excellence for Myelin Repair, a part of Mount Sinai, say gut bacteria produces compounds that have been seen to affect the myelin content in mice and cause social...

People with progressive MS make up around half of the UK’s 100,000 MS population, but according to a new report by the MS Trust growing pressures on NHS services mean they get much less support...

A new database containing nearly 2,500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.

This...

Tysabri didn't slow disability progression in patients with secondary progressive multiple sclerosis (SPMS).

The ASCEND trial missed its primary endpoint of reducing progression as measured...

A discussion organised by the Consortium of Multiple Sclerosis Centres (CMSC) has considered the role of vitamin D in multiple sclerosis (MS).

Researchers concluded that, while evidence is...

A test that measures olfactory dysfunction is an easy method of identifying patients with paediatric-onset multiple sclerosis (POMS) who are at increased risk of cognitive impairment, according to...

Pages

Live Chat Software by Click4Assistance UK